People
across the world are mourning the death of Apple co-founder Steve Jobs,
who passed away Wednesday, Oct 5, following a battle with pancreatic
cancer. Jobs' death has turned attention to rare form of cancer, for
which the U.S. Food and Drug Administration this May approved a new drug
- the first new option in nearly 30 years. Learn more about the drug,
everolimus, and how it's helping patients with pancreatic
neuroendocrine tumors.
By Lori Baker, MD Anderson Staff Writer
Not many emails make you cry. But tears
of joy rolled down Carmen Jacobs' face when she read that the drug
everolimus had been approved by the U.S. Food and Drug Administration
(FDA) for patients with pancreatic neuroendocrine tumors (pNET).
She
considers this treatment one of her biggest efforts as a research
nurse, and this news meant it had just been delivered to patients
everywhere. It's a much-anticipated arrival, since this is the first new
treatment option for these patients in nearly 30 years.
"I was
there when Dr. Yao treated the first patient in the very first clinical
trial about six years ago," says Jacobs, research nurse supervisor,
Gastrointestinal (GI) Medical Oncology, who also worked on each
subsequent trial. "I was so happy when I got his message saying it was
approved. Now all of these patients have access to a new treatment that
provides more hope for a longer and better life."
Idea Turns Into New Pancreatic Cancer Treatment
1 Comment
Leave a comment
- Global Navigation
- About Us
- Locations
- Calendar
- Careers
- How You Can Help
- Children's Art Project
- Directory
- Contact Us
- Sitemap
- Patient and Cancer Information
- myMDAnderson
- Cancer Information
- Patient Information
- Care Centers & Clinics
- Children’s Cancer Hospital
- Services & Amenities
- Clinical Trials
- News and Publications
- Newsroom
- Publications
- Education and Research
- Departments, Programs & Labs
- Research at MD Anderson
- Education & Training
- Resources for Professionals
- For Employees
- Employee Resources
- Doing Business
- Vendors & Suppliers
- Partners & Affiliates
- State of Texas
- State of Texas Home Page
- Statewide Search (TRAIL)
- State Comptroller - Where the Money Goes
- Texas Homeland Security
- The University of Texas System
- Institution Resume
- Legal and Policy
- Legal Statements & Site Policies
- Stay Connected
- Emergency Alerts
- Emergency Alert Information
© 2013 The University of Texas MD Anderson Cancer Center
I am so-o-o glad to hears of a new drug. I have several loved ones with MENI, who have had to have massive surgeries, maybe this will be able to help one of my children or grandchildren. Thanks to all who participated in the study!